Safety of two-hour intermittent intravenous infusions of tacrolimus in the allogeneic hematopoietic stem cell transplantation unit.

Saved in:
Bibliographic Details
Title: Safety of two-hour intermittent intravenous infusions of tacrolimus in the allogeneic hematopoietic stem cell transplantation unit.
Authors: Bacopoulos, Alexander JS1,2, Ho, Lina1,2,3, Yang, Anjie1,2, Ng, Pamela2, Dara, Celina2, Loach, David3,4, Deotare, Uday3,4, Michelis, Fotios V3,4, Viswabandya, Auro3,4, Kim, Dennis D3,4, Lipton, Jeffrey H3,4, Messner, Hans A3,4, Thyagu, Santhosh3,4 santhoth.thyagu@uhn.ca
Source: Journal of Oncology Pharmacy Practice. Jan2021, Vol. 27 Issue 1, p33-39. 7p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:10781552
DOI:10.1177/1078155220908948